1.Compilation Instruction and Key Point Interpretation for Guidelines for Construction of Traditional Chinese Medicine Pharmacovigilance System in Medical Institutions
Shuoshuo WEI ; Fumei LIU ; Li ZHANG ; Yuanyuan LI ; Zhifei WANG ; Xiaoxiao ZHAO ; Xin CUI ; Ruili WEI ; Shuo YANG ; Yanming XIE ; Lianxin WANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(8):229-237
The Guidelines for Construction of Traditional Chinese Medicine Pharmacovigilance Systems in Medical Institutions (T/CACM 1563.2-2024) were the first special guideline in China to systematically assist medical institutions in establishing a pharmacovigilance system tailored to the characteristics of traditional Chinese medicine (TCM). This guideline was jointly developed with 23 authoritative medical and research institutions in China, under the lead of the Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences. The purpose of this guideline was to standardize pharmacovigilance work throughout the entire lifecycle of TCM (including research and development, marketing, and application) and to establish a four-dimensional framework of "organizational structure, institutional system, information platform, and vigilance activities". Key components included the establishment of a TCM Safety Committee, the construction of nine core systems, the development of an information platform that complies with International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) E2B standards, alongside the risk monitoring, identification, assessment, and control during clinical trials and post-marketing phases. Therefore, this guideline filled a significant gap in the systemic standards for TCM safety management within medical institutions. Strictly adhering to domestic and international laws and regulations, the guideline compilation involved multiple rounds of expert interviews, systematic evidence integration, and broad consensus. This guideline was specified to be applicable to medical institutions at all levels, primarily addressing core issues, including the difficulty in adverse reaction identification, low reporting rates, and incomplete risk management chains due to the complex composition and diverse application of TCM. The compilation process was scientific and rigorous, ensuring alignment with current national laws and regulations, and was registered internationally. In the future, implementation will be promoted through standardized training, tiered dissemination, as well as a post-effect evaluation and dynamic revision mechanism starting two years after publication. All these aimed to enhance medical institutions' proactive capabilities in preventing and controlling TCM safety risks, ensure patient medication safety, and promote the high-quality development of TCM.
2.Compilation Instruction and Key Point Interpretation for Guidelines for Construction of Traditional Chinese Medicine Pharmacovigilance System in Medical Institutions
Shuoshuo WEI ; Fumei LIU ; Li ZHANG ; Yuanyuan LI ; Zhifei WANG ; Xiaoxiao ZHAO ; Xin CUI ; Ruili WEI ; Shuo YANG ; Yanming XIE ; Lianxin WANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(8):229-237
The Guidelines for Construction of Traditional Chinese Medicine Pharmacovigilance Systems in Medical Institutions (T/CACM 1563.2-2024) were the first special guideline in China to systematically assist medical institutions in establishing a pharmacovigilance system tailored to the characteristics of traditional Chinese medicine (TCM). This guideline was jointly developed with 23 authoritative medical and research institutions in China, under the lead of the Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences. The purpose of this guideline was to standardize pharmacovigilance work throughout the entire lifecycle of TCM (including research and development, marketing, and application) and to establish a four-dimensional framework of "organizational structure, institutional system, information platform, and vigilance activities". Key components included the establishment of a TCM Safety Committee, the construction of nine core systems, the development of an information platform that complies with International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) E2B standards, alongside the risk monitoring, identification, assessment, and control during clinical trials and post-marketing phases. Therefore, this guideline filled a significant gap in the systemic standards for TCM safety management within medical institutions. Strictly adhering to domestic and international laws and regulations, the guideline compilation involved multiple rounds of expert interviews, systematic evidence integration, and broad consensus. This guideline was specified to be applicable to medical institutions at all levels, primarily addressing core issues, including the difficulty in adverse reaction identification, low reporting rates, and incomplete risk management chains due to the complex composition and diverse application of TCM. The compilation process was scientific and rigorous, ensuring alignment with current national laws and regulations, and was registered internationally. In the future, implementation will be promoted through standardized training, tiered dissemination, as well as a post-effect evaluation and dynamic revision mechanism starting two years after publication. All these aimed to enhance medical institutions' proactive capabilities in preventing and controlling TCM safety risks, ensure patient medication safety, and promote the high-quality development of TCM.
3.Community Assembly and Antagonism Mechanisms of Rhizosphere Biocontrol Microorganisms for Disease Suppression in Medicinal Plants
Lingyun SUN ; Shuoshuo WANG ; Bingqian ZHOU ; Guohong YANG ; Yanling GENG ; Xiao WANG ; Wei LIU
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(24):315-322
The continuous cropping obstacles of medicinal plants seriously constrain the sustainable development of the Chinese medicinal material industry. A key contributing factor of continuous cropping obstacles is the long-term monoculture-caused imbalance in rhizosphere microbial composition. Rhizosphere biocontrol microorganisms, as "natural guardians" of the plant micro-ecosystem, help restore ecological balance through multiple mechanisms such as pathogen suppression, plant growth promotion, and induced systemic resistance, offering a promising approach to alleviating continuous cropping obstacles. This paper systematically elucidates the assembly mechanisms of rhizosphere biocontrol microbial communities of medicinal plants, with an emphasis on the signaling role of root exudates in the directional recruitment of microorganisms. It further addresses the synergistic regulatory effects of key factors—including soil physicochemical properties, host genetic characteristics, and microbial adaptability—on the structures and functions of biocontrol microbial communities. Additionally, the study clarifies five synergistic mechanisms by which biocontrol microorganisms antagonize pathogens: Nutrient and spatial competition, parasitism, formation of protective layers, secretion of antimicrobial compounds, and induction of plant systemic resistance, thereby constructing a disease-suppression network encompassing physical, chemical, and immune layers. In response to the limitations such as poor colonization capacity, narrow antagonistic spectra, and low stability of single-strain biocontrol agents in field applications, this paper innovatively proposes a tripartite collaborative strategy of "detoxification-growth promotion-quality improvement" though composite microbial consortia. By modulating the root exudate-microorganism interaction network, this approach synergistically enhances stress resistance and bioactive compound accumulation in medicinal plants, providing both a theoretical foundation and a technical pathway for the ecological cultivation of genuine medicinal plants.
4.Effects of Bushen Huatan Decoction on the β2AR/cAMP-PKA-CREB Signaling Pathway in a Rat Model of Postmenopausal Osteoporosis
Lin ZHANG ; Zhihao CHEN ; Shuoshuo YANG ; Chi CHEN ; Guangwen ZHOU
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2026;55(2):220-225
Objective To investigate the effects of Bushen Huatan decoction(BSHT) on the β2 adrenergic receptor(β2AR)and the cyclic AMP(cAMP)-protein kinase A(PKA)-cAMP response element binding protein(CREB)signaling pathway in ovariectomized rats. Methods A postmenopausal osteoporosis rat model was established by ovariectomy.30 rats were randomly divided into 3 groups:A sham operation (Sham)group,a model (OVX)group,and a (BSHT)group.5 weeks after the operation,the rats received different treatments(4 mL of normal saline for the Sham and OVX groups,and BSHT for the BSHT group).Micro-computed tomography(micro CT)was used to assess the microstructure of the femur.The mRNA and protein expression levels of β2AR,PKA,and CREB in the femur were detected by RT-PCR and Western blotting,respectively.The distribution of the proteins in femur tissue was determined by immunohistochemistry(IHC). Results Compared with the Sham group,the OVX group showed significantly decreased bone mineral density(BMD),bone volume fraction(BV/TV),trabecular thickness(Tb.Th),and trabecular number(Tb.N),as well as increased trabecular separation(Tb.Sp).The mRNA and protein levels of PKA and CREB were also decreased,while the mRNA and protein levels of β2AR were significantly increased(all P<0.05)in the OVX group.Compared with the OVX group,the BSHT group exhibited significantly increased BMD,BV/TV,Tb.Th,Tb.N,and expression levels of PKA and CREB,along with significantly decreased expression levels of β2AR(all P<0.05).IHC results showed that β2AR,PKA,and CREB were positively expressed in the cytoplasm of osteoblasts surrounding the trabeculae and in bone marrow stromal cells. Conclusion BSHT may prevent and treat osteoporosis in ovariectomized rats by regulating the expression of β2AR and the cAMP-PKA-CREB signaling pathway.
5.Repeatability and Reproducibility of a New Ocular Biometer Based on Partial Coherence Interferometry and Its Agreement with IOL Master 500
Shuoshuo CHEN ; Zhengfei YANG ; Zixuan LI ; Guitong YE ; Xiao YANG ; Mengyi WANG
Journal of Sun Yat-sen University(Medical Sciences) 2024;45(3):484-492
[Objective]To assess the repeatability(intra-operator variability)and reproducibility(inter-operator variability)of a new partial coherence interferometry(PCI)-based ocular biometer,Myopia Master,and its agreement with IOL Master 500 for measuring axial length(AL)and corneal curvature(K)in children aged 8-12 years.[Methods]The same operator measured school children with the Myopia Master and the IOL Master 500 in random order to assess agreement.Additionally,some of these children received measurements from another operator using the Myopia Master to assess repeatability and reproducibility.AL,flat keratometry(Kf),steep keratometry(Ks),mean keratometry(Km),J0 and J45 were analyzed.The repeatability and reproducibility were assessed by the within-subject standard deviation(Sw),test-retest repeatability(TRT),coefficient of variation(CoV)and intra-class correlation coefficient(ICC).The agree-ment between the Myopia Master and the IOL Master 500 was assessed by Bland-Altman plots and 95%limits of agree-ment(LoA).[Results]Both repeatability and reproducibility of the Myopia Master were high for AL measurements(Sw=0.02 mm,ICC=0.999;Sw=0.04 mm,ICC=0.998),but moderate for K measurements(Sw range,0.04 to 0.12 D,ICC range,0.861 to 0.991;Sw range,0.06 to 0.20 D,ICC range,0.835 to 0.992).There were significant mean differences be-tween the Myopia Master and the IOL Master 500 in measurements of AL(-0.01±0.04)mm,Kf(-0.09±0.15)D,Ks(-0.47±0.40)D,and Km(-0.28±0.23)D,J0(0.18±0.20)D and J45(-0.01±0.12)D.[Conclusions]The Myopia Master provided high repeatability and reproducibility for AL measurements in schoolchildren with myopia,but the Myopia Master and the IOL Master 500 cannot be used interchangeably in measuring AL and K.
6.Association of serum chemerin level with early renal insufficiency in patients with type 2 diabetes
Shuoshuo JIN ; Kuangyang CHEN ; Jiarong DAI ; Jie SHI ; Bin LU ; Weiwei ZHANG ; Yehong YANG ; Jie WEN ; Renming HU ; Zhen YANG ; Xuanchun WANG
Chinese Journal of Endocrinology and Metabolism 2022;38(6):509-516
Objective:To assess the correlation between circulating chemerin and two indicators of renal function, estimated glomerular filtration rate (eGFR) and urine albumin creatinine ratio (UACR), in individuals with type 2 diabetes and to determine whether chemerin is an independent marker of early renal insufficiency.Methods:A total of 742 patients with type 2 diabetes were recruited into the cross-sectional community study. Basic information, anthropometric parameters, and biochemical parameters of these individuals were determined and collected, and serum chemerin level was measured using enzyme-linked immunosorbent assay.Results:Chemerin levels were significantly higher in the eGFR-impaired group compared with eGFR-normal group, and macroalbuminuria group compared to the normal or microalbuminuria groups. Spearman′ rank correlation analysis showed serum chemerin level was correlated with eGFR ( r=-0.25, P<0.001), UACR ( r=0.23, P<0.001) and some other biochemical indicators such as triglyceride. And univariate and multivariate logistic regression analyses revealed circulating chemerin was an independent risk factor for eGFR impairment or proteinuria after adjusting corresponding covariates. Receiver operating characteristic (ROC) curve analysis showed that the area under curve (AUC) of circulating chemerin for predicting early impaired eGFR in type 2 diabetes was 0.747, while the AUC of circulating chemerin for predicting macroalbuminuria in type 2 diabetes was 0.748. Conclusion:Circulating chemerin is associated with eGFR or UACR and may be a potential diagnostic marker for early renal insufficiency in type 2 diabetes.
7.Analysis of Short-and Long-Term Therapeutic Efficacies of Acupuncture for Metabolic Syndrome
Zhihai HU ; Yi WANG ; Jingjing ZHANG ; Aijia ZHANG ; Yang CAO ; Linjing CHEN ; Qun LU ; Shuoshuo WANG ; Manhuai HONG
Shanghai Journal of Acupuncture and Moxibustion 2016;35(4):399-401
Objective To observe the short- and long-term efficacies of acupuncture in treating metabolic syndrome (MS). Method A hundred MS patients were randomized into an acupuncture group and a Western medication group. In addition to basic treatment, acupuncture was used in the acupuncture group, while Western medication was adopted in the Western medication group. The fasting plasma glucose (FPG), high-density lipoprotein (HDL), insulin (INS), triglyceride (TG), blood pressure (BP), weight circumference (WC), body mass index (BMI), and MS score were evaluated before and after treatment, and a month and 3 months after the treatment. Result There was no significant difference in comparing the short-term therapeutic efficacy between the two groups after treatment, while the long-term therapeutic efficacy of the acupuncture group was superior to that of the Western medication group (P<0.01); the FPG, INS, TG, HDL, BP, and MS score were significantly improved after treatment and a month after the treatment in both groups (P<0.01); the acupuncture group had significant improvements in WC and BMI after treatment and a month after the treatment (P<0.01), significantly superior to the Western medication group (P<0.01); the acupuncture group showed marked improvement in INS, HDL, WC, and BMI 3 months after the treatment (P<0.01), significantly superior to the Western medication group (P<0.01,P<0.05). Conclusion Acupuncture can produce a similar short-term but a better long-term therapeutic efficacy compared to Western medication. Hence, acupuncture can be taken as an assistant intervention for MS.


Result Analysis
Print
Save
E-mail